209 related articles for article (PubMed ID: 15289136)
21. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
[TBL] [Abstract][Full Text] [Related]
22. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
[TBL] [Abstract][Full Text] [Related]
23. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8.
Kaiser PK;
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1132-42. PubMed ID: 16538452
[TBL] [Abstract][Full Text] [Related]
24. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
Wykrota H; Gierek-Łapińska A
Klin Oczna; 2002; 104(3-4):239-43. PubMed ID: 12608309
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in serpiginous choroiditis.
Park SP; Ko DA; Chung H; Yu HG
Ophthalmic Surg Lasers Imaging; 2006; 37(5):425-8. PubMed ID: 17017204
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy.
Ergun E; Tittl M; Stur M
Arch Ophthalmol; 2004 Jan; 122(1):37-41. PubMed ID: 14718292
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.
Axer-Siegel R; Ehrlich R; Weinberger D; Rosenblatt I; Shani L; Yassur Y; Priel E; Kramer M
Am J Ophthalmol; 2004 Oct; 138(4):602-7. PubMed ID: 15488787
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy.
Coco RM; de Souza CF; Sanabria MR
Ocul Immunol Inflamm; 2007; 15(1):27-9. PubMed ID: 17365803
[TBL] [Abstract][Full Text] [Related]
30. Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin.
Chan WM; Lam DS; Lai TY; Yuen KS; Liu DT; Chan CK; Chen WQ
Am J Ophthalmol; 2003 Nov; 136(5):836-45. PubMed ID: 14597034
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration.
Pece A; Isola V; Vadalà M; Calori G
Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590
[TBL] [Abstract][Full Text] [Related]
32. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.
Pieramici DJ; Bressler SB; Koester JM; Bressler NM
Arch Ophthalmol; 2006 May; 124(5):660-4. PubMed ID: 16682587
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
Pece A; Vadalà M; Isola V; Matranga D
Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
[TBL] [Abstract][Full Text] [Related]
34. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
Spaide RF; Sorenson J; Maranan L
Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
[TBL] [Abstract][Full Text] [Related]
35. Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.
Costagliola C; Campa C; Incorvaia C; Parmeggiani F; Menzione M; Della Corte M; Rinaldi M; Romano M; Semeraro F
Eur J Ophthalmol; 2008; 18(6):955-9. PubMed ID: 18988168
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia.
Bandello F; Lanzetta P; Battaglia Parodi M; Roman-Pognuz D; Saviano S; Ravalico G
Graefes Arch Clin Exp Ophthalmol; 2003 Jul; 241(7):567-570. PubMed ID: 12819976
[TBL] [Abstract][Full Text] [Related]
38. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
39. Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin.
Blair MP; Apte RS; Miskala PH; Bressler SB; Goldberg MF; Schachat AP; Bressler NM
Retina; 2004 Aug; 24(4):501-6. PubMed ID: 15300069
[TBL] [Abstract][Full Text] [Related]
40. Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks.
Shaikh S; Ruby AJ; Williams GA
Am J Ophthalmol; 2003 Jan; 135(1):1-6. PubMed ID: 12504689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]